PROCEPT BioRobotics (MEX:PRCT) Beginning Cash Position: MXN5,221 Mil (As of Mar. 2026)


MEX:PRCT PROCEPT BioRobotics Corp MEX:PRCT
54 GF Score
Price MXN358.45
GF Value MXN1,463.67
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is PROCEPT BioRobotics Beginning Cash Position?

PROCEPT BioRobotics MEX:PRCT 54 Beginning Cash Position is MXN5,221 Mil as of Mar. 2026. GuruFocus rates MEX:PRCT with a GF Score™ of 54/100 and a GF Value™ of MXN1,463.67 (Significantly Undervalued). The stock has 2 warning signs investors should review.

PROCEPT BioRobotics's Beginning Cash Position for the quarter that ended in Mar. 2026 was MXN5,221 Mil.

PROCEPT BioRobotics's quarterly Beginning Cash Position declined from Sep. 2025 (MXN5,609 Mil) to Dec. 2025 (MXN5,353 Mil) and declined from Dec. 2025 (MXN5,353 Mil) to Mar. 2026 (MXN5,221 Mil).

PROCEPT BioRobotics's annual Beginning Cash Position increased from Dec. 2023 (MXN3,831 Mil) to Dec. 2024 (MXN5,428 Mil) and increased from Dec. 2024 (MXN5,428 Mil) to Dec. 2025 (MXN6,064 Mil).

PROCEPT BioRobotics Beginning Cash Position Related Terms

PROCEPT BioRobotics Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for PROCEPT BioRobotics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PROCEPT BioRobotics Beginning Cash Position Chart

PROCEPT BioRobotics Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial 2,070.01 5,948.17 3,830.65 5,427.91 6,063.65

PROCEPT BioRobotics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,889.56 6,011.13 5,608.83 5,353.44 5,221.19
MEX:PRCT
54GF Score
PROCEPT BioRobotics Corp MEX:PRCT
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PROCEPT BioRobotics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of MXN5,221 Mil mean?
PROCEPT BioRobotics (MEX:PRCT) has a Beginning Cash Position of MXN5,221 Mil as of Mar. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on PROCEPT BioRobotics and its competitors.
Is PROCEPT BioRobotics' Beginning Cash Position too high?
PROCEPT BioRobotics' current Beginning Cash Position is MXN5,221 Mil. Overall, PROCEPT BioRobotics has a GF Score™ of 54/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PROCEPT BioRobotics' Beginning Cash Position compare to ALMR and AHCO?
PROCEPT BioRobotics' Beginning Cash Position of MXN5,221 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Devices & Instruments company?
A good Beginning Cash Position depends on the Medical Devices & Instruments industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on PROCEPT BioRobotics and its competitors. PROCEPT BioRobotics's current Beginning Cash Position is MXN5,221 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PROCEPT BioRobotics stock overvalued right now?
Based on GuruFocus' analysis, PROCEPT BioRobotics (MEX:PRCT) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN1,463.67, compared to a current price of MXN358.45 — trading 75.5% below its estimated fair value. The current Beginning Cash Position is MXN5,221 Mil. PROCEPT BioRobotics' overall GF Score™ is 54/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For PROCEPT BioRobotics (MEX:PRCT), the current Beginning Cash Position is MXN5,221 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PROCEPT BioRobotics (MEX:PRCT) Overvalued in 2026?

Based on GuruFocus' analysis, PROCEPT BioRobotics stock appears to be undervalued. The current stock price of MXN358.45 is trading 75.5% below its estimated GF Value™ of MXN1,463.67. GuruFocus considers PROCEPT BioRobotics to be Significantly Undervalued.

Key valuation signals for MEX:PRCT:

  • Beginning Cash Position: MXN5,221 Mil
  • GF Value™: MXN1,463.67 vs. price of MXN358.45 (75.5% below fair value)
  • GF Score™: 54/100 with 2 warning signs

No single metric tells the full story. See the MEX:PRCT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PROCEPT BioRobotics Business Description

Other Exchanges PRCT:USA
Address 150 Baytech Drive, San Jose, CA, USA, 95134
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
54GF Score

Get the complete analysis for MEX:PRCT

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN358.45
Price
MXN1,463.67
GF Value